Nader Z. Pourhassan
2022
In 2022, Nader Z. Pourhassan earned a total compensation of $6M as President and Chief Executive Officer at CytoDyn, a 40% decrease compared to previous year.
Compensation breakdown
| Option Awards | $4,587,075 |
|---|---|
| Salary | $431,210 |
| Other | $1,010,436 |
| Total | $6,028,721 |
Pourhassan received $4.6M in option awards, accounting for 76% of the total pay in 2022.
Pourhassan also received $431.2K in salary and $1M in other compensation.
Rankings
In 2022, Nader Z. Pourhassan's compensation ranked 506th out of 5,760 executives tracked by ExecPay. In other words, Pourhassan earned more than 91.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 506 out of 5,760 | 91st |
Division Manufacturing | 209 out of 3,136 | 93rd |
Major group Chemicals And Allied Products | 60 out of 1,422 | 96th |
Industry group Drugs | 48 out of 1,323 | 96th |
Industry Pharmaceutical Preparations | 34 out of 969 | 97th |
Source: SEC filing on October 26, 2022.
Pourhassan's colleagues
We found four more compensation records of executives who worked with Nader Z. Pourhassan at CytoDyn in 2022.